Legal: Failure to diagnose preeclampsia alleged
Preeclampsia not diagnosed, placental abruption follows, and fetus is stillborn.
A 30-year-old Illinois woman presented to the hospital in 2000 during her pregnancy. A UTI was diagnosed and she was admitted overnight for monitoring and treatment and was discharged the next day. Two days later, she developed eclampsia and had a placental abruption and the fetus was delivered stillborn. She was admitted to the ICU for 9 days with complications, including thrombotic episodes and temporary blindness.
She sued the physicians and hospital and claimed they failed to diagnose preeclampsia and HELLP syndrome when she was first admitted and were negligent in releasing her from the hospital.
The physicians argued that the placental abruption, stillbirth, and complications were due to antiphospholipid-antibody syndrome that was unknown to them at the time. They maintained the diagnosis of UTI was correct and that the patient was given instructions to see her obstetrician within 24 hours of discharge from the hospital and she failed to do so. The hospital settled for $125,000 just prior to trial and a $1.8 million verdict was returned against the treating obstetrician.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
